Cargando…
New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines
BACKGROUND: Viral vectors are invaluable tools to transfer genes and/or regulatory sequences into differentiated cells such as pancreatic cells. To date, several kinds of viral vectors have been used to transduce different pancreatic cell types, including insulin-producing β cells. However, few stud...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580483/ https://www.ncbi.nlm.nih.gov/pubmed/31208395 http://dx.doi.org/10.1186/s12896-019-0531-9 |
_version_ | 1783428028586524672 |
---|---|
author | Albagli, Olivier Maugein, Alicia Huijbregts, Lukas Bredel, Delphine Carlier, Géraldine Martin, Patrick Scharfmann, Raphaël |
author_facet | Albagli, Olivier Maugein, Alicia Huijbregts, Lukas Bredel, Delphine Carlier, Géraldine Martin, Patrick Scharfmann, Raphaël |
author_sort | Albagli, Olivier |
collection | PubMed |
description | BACKGROUND: Viral vectors are invaluable tools to transfer genes and/or regulatory sequences into differentiated cells such as pancreatic cells. To date, several kinds of viral vectors have been used to transduce different pancreatic cell types, including insulin-producing β cells. However, few studies have used vectors derived from « simple » retroviruses, such as avian α- or mouse γ-retroviruses, despite their high experimental convenience. Moreover, such vectors were never designed to specifically target transgene expression into β cells. RESULTS: We here describe two novel α- or SIN (Self-Inactivating) γ-retrovectors containing the RIP (Rat Insulin Promoter) as internal promoter. These two retrovectors are easily produced in standard BSL2 conditions, rapidly concentrated if needed, and harbor a large multiple cloning site. For the SIN γ-retrovector, either the VSV-G (pantropic) or the retroviral ecotropic (rodent specific) envelope was used. For the α-retrovector, we used the A type envelope, as its receptor, termed TVA, is only naturally present in avian cells and can efficiently be provided to mammalian β cells through either exogenous expression upon cDNA transfer or gesicle-mediated delivery of the protein. As expected, the transgenes cloned into the two RIP-containing retrovectors displayed a strong preferential expression in β over non-β cells compared to transgenes cloned in their non-RIP (CMV- or LTR-) regulated counterparts. We further show that RIP activity of both retrovectors mirrored fluctuations affecting endogenous INSULIN gene expression in human β cells. Finally, both α- and SIN γ-retrovectors were extremely poorly mobilized by the BXV1 xenotropic retrovirus, a common invader of human cells grown in immunodeficient mice, and, most notably, of human β cell lines. CONCLUSION: Our novel α- and SIN γ-retrovectors are safe and convenient tools to stably and specifically express transgene(s) in mammalian β cells. Moreover, they both reproduce some regulatory patterns affecting INSULIN gene expression. Thus, they provide a helpful tool to both study the genetic control of β cell function and monitor changes in their differentiation status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12896-019-0531-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6580483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65804832019-06-24 New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines Albagli, Olivier Maugein, Alicia Huijbregts, Lukas Bredel, Delphine Carlier, Géraldine Martin, Patrick Scharfmann, Raphaël BMC Biotechnol Research Article BACKGROUND: Viral vectors are invaluable tools to transfer genes and/or regulatory sequences into differentiated cells such as pancreatic cells. To date, several kinds of viral vectors have been used to transduce different pancreatic cell types, including insulin-producing β cells. However, few studies have used vectors derived from « simple » retroviruses, such as avian α- or mouse γ-retroviruses, despite their high experimental convenience. Moreover, such vectors were never designed to specifically target transgene expression into β cells. RESULTS: We here describe two novel α- or SIN (Self-Inactivating) γ-retrovectors containing the RIP (Rat Insulin Promoter) as internal promoter. These two retrovectors are easily produced in standard BSL2 conditions, rapidly concentrated if needed, and harbor a large multiple cloning site. For the SIN γ-retrovector, either the VSV-G (pantropic) or the retroviral ecotropic (rodent specific) envelope was used. For the α-retrovector, we used the A type envelope, as its receptor, termed TVA, is only naturally present in avian cells and can efficiently be provided to mammalian β cells through either exogenous expression upon cDNA transfer or gesicle-mediated delivery of the protein. As expected, the transgenes cloned into the two RIP-containing retrovectors displayed a strong preferential expression in β over non-β cells compared to transgenes cloned in their non-RIP (CMV- or LTR-) regulated counterparts. We further show that RIP activity of both retrovectors mirrored fluctuations affecting endogenous INSULIN gene expression in human β cells. Finally, both α- and SIN γ-retrovectors were extremely poorly mobilized by the BXV1 xenotropic retrovirus, a common invader of human cells grown in immunodeficient mice, and, most notably, of human β cell lines. CONCLUSION: Our novel α- and SIN γ-retrovectors are safe and convenient tools to stably and specifically express transgene(s) in mammalian β cells. Moreover, they both reproduce some regulatory patterns affecting INSULIN gene expression. Thus, they provide a helpful tool to both study the genetic control of β cell function and monitor changes in their differentiation status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12896-019-0531-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-17 /pmc/articles/PMC6580483/ /pubmed/31208395 http://dx.doi.org/10.1186/s12896-019-0531-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Albagli, Olivier Maugein, Alicia Huijbregts, Lukas Bredel, Delphine Carlier, Géraldine Martin, Patrick Scharfmann, Raphaël New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines |
title | New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines |
title_full | New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines |
title_fullStr | New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines |
title_full_unstemmed | New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines |
title_short | New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines |
title_sort | new α- and sin γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580483/ https://www.ncbi.nlm.nih.gov/pubmed/31208395 http://dx.doi.org/10.1186/s12896-019-0531-9 |
work_keys_str_mv | AT albagliolivier newaandsingretrovectorsforsafetransductionandspecifictransgeneexpressioninpancreaticbcelllines AT maugeinalicia newaandsingretrovectorsforsafetransductionandspecifictransgeneexpressioninpancreaticbcelllines AT huijbregtslukas newaandsingretrovectorsforsafetransductionandspecifictransgeneexpressioninpancreaticbcelllines AT bredeldelphine newaandsingretrovectorsforsafetransductionandspecifictransgeneexpressioninpancreaticbcelllines AT carliergeraldine newaandsingretrovectorsforsafetransductionandspecifictransgeneexpressioninpancreaticbcelllines AT martinpatrick newaandsingretrovectorsforsafetransductionandspecifictransgeneexpressioninpancreaticbcelllines AT scharfmannraphael newaandsingretrovectorsforsafetransductionandspecifictransgeneexpressioninpancreaticbcelllines |